Peter Pfreundschuh

Peter Pfreundschuh serves as Chief Financial Officer at Y-mAbs Therapeutics, Inc., and has held the same title at Frequency Therapeutics and UroGen Pharmaceuticals Ltd. Additionally, Peter Pfreundschuh is a member of the Board of Directors at NorthStar Medical Technologies, LLC, and previously worked as Chief Financial Officer and Senior Financial Advisor at Voyager Therapeutics, Inc. Peter Pfreundschuh completed Masters Coursework in Strategic Marketing for the Healthcare Industry at Northwestern University's Kellogg School of Management and holds an MBA with concentrations in Finance and Marketing from Rider University Graduate School of Business.